Abstract Since the mid-1980s the number of cases of TB notified within the U.K. has continued to rise although the contribution of HIV to this rise remains unclear. A12-month prospective cohort study was conducted at chest and HIV clinics in four hospitals in Lambeth, Southwark and Lewisham (LSL), an area of South London, to determine the proportion of patients with culture-provenTB infected with HIV. Secondary aims were to determine the proportion of patients withTB and undiagnosed HIV at first presentation to chest clinics, to determine the proportion of patients presenting withTB as an AIDS defining illness (ADI) and to identify risk factors for co-infection withTB and HIV. In chest clinics, demographic data and left-over blood from patients aged 16 or over with culture-provenTB was collected, anonymised and HIV tested. In HIV clinics, demographic data on patients withTB already known to be HIV seropositive were also obtained.Twenty-one patients (13%, 95% CIF8^19%) of 159 with culture-provenTB were infected with HIV. Four (3%) of 133 patients at first presentation to chest clinics had undiagnosed HIV; two were subsequently diagnosed. Of the 21 patients withTB and HIV, nine (43%) presented withTB as an ADI.Patients withTB and HIV were significantly morelikely to be aged between 35 and 55 years compared to HIV seronegative patients [12/21 (57%) vs. 38/138 (28%), P=0.006]. None ofthe patients from the Indian Subcontinent were HIV seropositive [0/21vs. 25/138 (18%), P=0.047]. Atthe present time, universal HIV testing of patients with culture-provenTB in chest clinics within the U.K. is unlikely to significantly reduce the number of patients with undiagnosed HIV. r
INTRODUCTION
During the mid-1980s, the decline in noti¢ed cases of tuberculosis (TB) within the U.K. was reversed and the highest increases were noted in London and inner city areas. In 1998, over 6000 new cases of TB were noti¢ed and in London noti¢cation rates were three times the national average. Nearly 50% of all new cases were diagnosed in ethnic minority groups including recently arrived immigrants from areas of high HIV prevalence (1) . Although HIV increases the likelihood that infection will progress to disease (2), HIV was not thought to have signi¢cantly contributed to the U.K. rise in noti¢ed cases of TB (3, 4) .
Guy's, St Thomas', King's College and Lewisham Hospitals serve the South London communities of Lambeth, Southwark and Lewisham (LSL). Approximately one million people live within these communities and 25% are from ethnic minority groups compared to an average of 6% for England and Wales. In 1998, approximately 500 new cases of HIV were diagnosed and noti¢ed in LSL and TB rates exceeded 30/100 000, the seventh highest in the U.K. (1) .
The primary aim of this study was to determine the proportion of patients with culture-proven TB also infected with HIV in LSL. The secondary aims were to determine the proportion of patients with culture-proven TB and undiagnosed HIVattending chest clinics, to determine the proportions of patients with TB and HIV presenting with TB as an AIDS de¢ning illness (ADI) and to identify risk factors forTB and HIV co-infection.
METHODS
Between December 1999 and November 2000, patients aged16 years or older with newly diagnosed or recurrent culture-proven TB were recruited into this prospective cohort study. A research nurse collected demographic data (age range, sex, country of origin, self-reported ethnicity and year of arrival in the U.K.) on patients with suspected TB attending chest clinics. Following blood tests taken for other purposes, leftover serum of suspected TB patients was stored at À201C. When M. tuberculosis was cultured from clinical specimens, serum samples were allocated a random number and unlinked to all identi¢ers before HIV testing. All outpatient chest clinics displayed a Department of Health poster explaining, in 14 di¡erent languages, that left-over blood could be anonymised and HIV tested. A lea£et was available to reinforce this message. Patients could have refused to allow their serum to be tested anonymously. Eligible samples were tested at the end of the study after all data entry had been checked. Ethical approval was obtained from the ethics committees of Guy's and St Thomas' Hospital, King's College Hospital and Lewisham Hospital.
Demographic data on patients withTB, already known to be HIV seropositive and attending HIV clinics, were obtained by reference to notes and consultation with HIV physicians. The proportion of patients presenting withTB as an ADI was established.
Mycobacterial cultures
All pulmonary and extrapulmonary samples were auramine stained and subcultured onto Lowenstein^Jensen and Middlebrook's media. All smear positive and extrapulmonary samples were directly inoculated into Kirschner's broth and the automated liquid MB/BacT system (OrganonTeknika,Cambridge,U.K.) to expedite the time to culture. Speciation was determined by biochemical testing and DNA hybridisation (Accuprobe) and antimicrobial susceptibility performed using the resistance ratio method on Lowenstein^Jensen medium or the radiometric BACTEC 460 method (5) .
HIV testing
Fifty microlitres of patient serum were pooled in batches of 10 and each pool tested for HIV antibodies (Microparticle enzyme immunoassay (MEIA), Abbott Axsym system). Previous studies have demonstrated that pooling and10 -fold dilution of serum does not signi¢cantly lower the sensitivity of HIV testing (6) . Samples in HIV reactive pools were re-tested individually. Reactive samples were con¢rmed by a Wellcozyme HIV-1 speci¢c competitive ELISA (Murex Biotech Ltd, Dartford, U.K.) and an HIV-1 speci¢c gel particle agglutination assay (Serodia, Fujireibo Inc, Tokyo, Japan). No second samples were available for con¢rmatory tests.
Statistical analysis
Sample size: If 2000 patients with culture-proven TB are noti¢ed in the U.K. each year and we estimate that 10% are HIV infected, then a sample size of159 has 80% power (a=0.05) to detect 19% compared to a postulated prevalence of 10%.
Demographics: The characteristics of patients were analysed using simple descriptive statistics (percentages or proportions). Proportions were compared using the Chi-squared test, or Fisher's exact test when the numbers were small.
RESULTS
Two hundred and sixteen (69%) of 313 patients with AFB seen in clinical specimens or culture positive mycobacterial infection had culture-proven TB (Table 1) . Fifty-seven (26%) of these 216 patients were excluded from the study. These included patients who died early or remained hospitalised during the study period, patients diagnosed in LSL but treated outside our South London catchment area, patients who failed to attend or were not referred to chest clinic and patients who were di⁄cult to bleed. The HIV serostatus of 159 (74%) of 216 patients was determined and 21 (13%, 95% CIF8^19%) were found to be HIV seropositive.
In chest clinics, four (3%) of 133 patients with cultureprovenTB had undiagnosed HIV, two were subsequently diagnosed as part of routine clinical care (Table1).Of the 21patients withTB and HIV, nine (43%) presented withTB as an ADI,10 (48%) were already attending HIV clinics and were known to be HIV seropositive and two (9%) continued to attend chest clinics with undiagnosed HIV (Table 2) . Seven of the nine presenting withTB as an ADI were voluntarily HIV tested as medical inpatients before referral to HIV clinics. None of the ten in HIV clinics had been prescribed primaryTB chemoprophylaxis.
Patients with TB and HIV infection were signi¢cantly more likely to be aged 35^55 years [12/21 (57%) vs. 38/ 138 (28%); P=0.006] compared to those testing HIV seronegative. None of the 25 patients from the Indian Subcontinent were HIV seropositive [0/21 vs. 25/138 (18%), P=0.047]. There was no signi¢cant di¡erence between HIV seropositive and seronegative patients for ¢rst or recurrent TB infections, sex, country of origin or year of arrival in the U.K. A higher percentage of ethnic 'Black Africans' and patients arriving in the U.K. after1995 were HIV seropositive, but these di¡erences were not statistically signi¢cant (Table 3) .
DISCUSSION Principal ¢ndings
Twenty-one (13%, 95% CIF8^19%) of 159 patients diagnosed with culture-proven TB were infected with HIV. Four (3%) of 133 patients with culture-provenTB at ¢rst presentation to chest clinic had HIV. Two remained undiagnosed and it is possible they were o¡ered HIV test-ing but refused. Nine (43%) of the 21patients withTB and HIV presented with TB as an ADI. Patients with TB and HIV were signi¢cantly more likely to be aged 35^55 years and less likely to be from the Indian Subcontinent.
Strengths of study
To avoid ascertainment bias only patients with cultureprovenTB were recruited into this study. Inclusion of patients on the basis of smear positivity alone would have resulted in 79 extra patients with mycobacteria other than M. tuberculosis (MOTT). Although not all patients withTB are culture positive, the use of automated liquid MB/BacT culture systems increased the sensitivity of culture, in particular, of extra-pulmonary samples (7) .
Of the 216 patients with culture-proven TB, 57 (26%) were excluded from the study. There was no signi¢cant di¡erence for ¢rst or recurrent infection, age range, sex, site of disease, country of origin, year of arrival and drug susceptibilities between those included and excluded from the study.
Passive consent was obtained for HIV testing of leftover blood by displaying a poster in the chest clinic. This method of consent minimised the potential for selection bias as no one refused blood tests. Access to virological and microbiological databases and notes in chest and HIV clinics enabled us to calculate not only a co-infection rate but also the proportion of patients who presented with TB as an ADI.
The study was conducted in an area of highTB and HIV prevalence.Our conclusions are applicable to other areas within the U.K. where the proportion of patients withTB and undiagnosed HIV at ¢rst presentation to chest clinic is likely to be less.
Limitations of study
Only demographic data on patients attending chest clinics were prospectively collected. Data on patients attending HIV clinics were collected retrospectively and recall and recording bias may have a¡ected the quality of this data. Amongst the 57 patients excluded, three died before a blood sample could be obtained. In comparison to patients who survived, one might expect that these three were more likely to be HIV infected although clinically this was not apparent.
Previous prospective studies in London
Two other prospective cohort studies have been conducted at London hospitals. In one smaller study, blood samples were taken from patients 2 weeks after the initiation of anti-TB therapy and leftover blood was anonymised and tested for HIV. The detectable rate of HIV amongst patients with culture-provenTB was 16 (23.5%) out of 68.Thirty-seven out of 39 patients were detected by voluntary testing, suggesting that o¡ers of HIV testing to patients with TB are largely taken up by those at risk of HIV infection (8) .
A larger study in Southwest London, adjacent to LSL, estimated that the rate of HIV and TB co-infection was 11.4% (9) . Although this study also involved patients with culture-proven TB there were important di¡erences in the manner that patients were recruited.The Southwest study recruited patients fromTB contact, chest and 'new entrant'clinics whereas we recruited patients from chest and HIV clinics. When patients with TB attending non-HIV clinics are compared, the proportion of patients withTB and undiagnosed HIV is signi¢cantly di¡erent [4/ 133 (3%), LSL vs. 23/202 (11.4%), Southwest London (P=0.006)].This di¡erence might be explained by the willingness of non-HIV physicians in LSL to o¡er HIV tests to patients with suspected TB at ¢rst presentation and, if seropositive, to refer to HIV clinics.There was no statistical di¡erence between patients presenting with TB as an ADI [9/159 (5 
Strategies for detecting undiagnosed HIV associated withTB
Within our study the awareness that TB can present as an ADI is partly a consequence of the reporting method of smear positive or culture positive results. A microbiologist telephoned results to physicians, and demographic, clinical and radiological information was obtained for each case. Physicians were asked to consider HIV testing depending upon perceived risk (age, ethnicity, sexuality, intravenous drug use, place of origin, date of arrival in the U.K. and site of disease). Laboratories have an important role in increasing awareness of TB as an ADI, and a standard comment attached to laboratory reports such as 'TB occurs more commonly in immunocompromised patients' may help to reduce the number of undiagnosed HIV infections.
Should all patients with suspected tuberculosis be counselled and o¡ered HIV testing in London by April 2002 as recommended by the LondonTB Group and Regional O⁄ce (10)? The advantage of this strategy is that it provides an opportunity to diagnose all patients withTB and HIV. HIV seropositive patients could then be o¡ered prophylaxis against opportunistic infections and HAART capable of suppressing viral loads and improving prognosis. However, this and other London-based studies demonstrate that the great majority of patients withTB are not infected with HIV. Patients may feel further stigmatised by routine HIV testing (11, 12) and be less inclined to attend clinic and take medication regularly, resulting in more treatment failures and more drug-resistant TB (13) .
Our study shows that the majority of patients withTB and HIV accept voluntary testing and are diagnosed outside chest clinics. In general, we have a low threshold for recommending HIV testing to patients withTB.We have demonstrated that patients with TB do not have the same risk for HIV (e.g. elderly patients and patients from the Indian Subcontinent) and believe that there should be exceptions to universal HIV testing. Provided laboratories and public health physicians continue to raise awareness of the association between TB and HIV and non-HIV physicians remain willing to o¡er HIV testing to 'at-risk' patients, few patients with culture-proven TB will remain undiagnosed. Repeated prospective anonymised studies HIV testing patients with TB are, however, essential to ensure this remains the case.
The role of primaryTB chemoprophylaxis
In our study,TB in approximately 50% of patients withTB and HIV might have been prevented by primary TB chemoprophylaxis. Prospective randomised control trials from the pre-HAARTera have demonstrated the bene¢t of isoniazid prophylaxis in HIV-1 infected patients (14, 15) . Primary TB chemoprophylaxis is not currently recommended in British Thoracic Society (BTS) guidelines (16) as HAART remains the most important option in any country with access to anti-retroviral drugs. However, it is possible that chemoprophylaxis may have a role in preventing activeTB and in the post-HAARTera further studies are required.
CONCLUSION
The rate of culture-provenTB and HIV co-infectivity in a South London community of highTB and HIV prevalence was 13%. The study also identi¢ed a group of patients most likely to be infected withTB and HIV.The majority of patients withTB and HIVaccepted voluntary HIV testing and were diagnosed outside of chest clinics. Less than 2% of patients with TB when discharged from chest clinics had undiagnosed HIV. At the present time, when approximately 500 new cases of HIVare noti¢ed annually in LSL, universal HIV testing in chest clinics is unlikely to signi¢cantly reduce the number of patients with undiagnosed HIV.
